Kenneth B. Lee, Jr.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Kenneth B. Lee, Jr.
Earlier roles on record: Board Member at Biocryst Pharmaceuticals Inc (BCRX) until December 31, 2023. Biocryst Pharmaceuticals Inc reported in an 8-K filed December 1, 2023 that Kenneth B. Lee, Jr. retired as Board of Directors, effective December 31, 2023.
“On November 28, 2023, Kenneth B. Lee, Jr. notified BioCryst Pharmaceuticals, Inc. (the "Company") of his intention to retire from the Board of Directors of the Company (the "Board"), effective December 31, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2022-06-07–2023-12-31
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.